The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has been approved for research funding by the Patient-Centered Outcomes Research Institute to study whether adding chemotherapy before standard treatment with immunotherapy, radiation, and surgery for certain sarcomas will reduce the risk of the cancer returning.
Reimagine Care and Tampa General Hospital Cancer Institute are teaming up to expand access, increase clinical capacity, and improve cancer care delivery across the Tampa Bay region.
Dimple Patel recently joined the executive leadership team at VCU Massey Comprehensive Cancer Center, where she will serve as the associate director for innovation, leadership, and professional development. Patel brings 25 years of leadership experience spanning six public and private institutions of higher education.
Khalil Choucair has joined the thoracic oncology and phase I clinical trials multidisciplinary teams as a medical oncologist at Karamos Cancer Institute.
The National Academy of Inventors has elected the newest class of Fellows, naming 169 U.S. distinguished academic and institutional inventors and 16 International Fellows to the 2025 cohort.
Cynthia R. Moran, executive vice president of government relations, economics, and health policy at the American College of Radiology, will retire effective Jan. 2, 2026.
Renuka Iyer was appointed chief medical officer for the National Comprehensive Cancer Network—an alliance of leading cancer centers that publishes free evidence-based, expert consensus-driven guidelines for cancer prevention and care.
Wafik S. El-Deiry was re-elected as the chair of the WIN Consortium in Precision Oncology.
The American Association for Cancer Research’s Project GENIE (Genomics Evidence Neoplasia Information Exchange), the world’s largest publicly accessible cancer registry of real-world clinico-genomic data, was selected as a winner of the 2025 Amazon Web Services Imagine Grant.
Robin Toft was appointed CEO of Curebound, a philanthropic organization that fundraises for and invests in cancer research, effective Jan. 1.
